glp-1 agonist review Frontiers Current Insights, Advantages and Challenges

However, renal effects of GLP-1 in heart failure (HF) has not been elucidated

Semaglutide, the active ingredient in GLP-1 drugs, was associated with a lower risk of worsening mental health, a study published in Lancet Psychiatry found.

The answer is yes

Medicaid coverage for weight loss medications, including GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound), varies dramatically from state to sta...

The aim of this narrative review is to critically assess the renoprotective effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in managing albuminuria among patients with type 2 diabetes mellitus within the framework of personalized ...